A Study of Neoadjuvant Nivolumab + Abemaciclib or Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer

Conditions:   Breast Cancer;   Cancer Interventions:   Biological: Nivolumab;   Drug: Abemaciclib;   Drug: Anastrozole;   Drug: Palbociclib Sponsor:   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials